Your Article Summary
See Latest ArticlesLumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06
Lumenis Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced that it has received exclusive worldwide licensing rights for SRT(TM), a new laser therapy for selectively treating retinal diseases. These rights include licenses issued to Lumenis by Medizinisches Laserzentrum Lubeck GmbH, Massachusetts General Hospital and Professor Reginald Birngruber
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09